Using ovarian cancer PDX models, SMYD3 was identified to induce ovarian cancer growth 97, and to promote metastasis and reduce ascites volume in ovarian cancer PDX models 98, suggesting that SMYD3 may be related to the development of ovarian cancer. Here, SMYD3 is linked to ovarian cancer.